Clinical Trial Update: Thalidomide to Overcome Lenalidomide Resistance After Autologous Hematopoietic Stem Cell Transplantation (HCT) [NA]

View source ↗

Summary

A terminated clinical trial evaluating thalidomide to overcome lenalidomide resistance after autologous stem cell transplantation in myeloma patients; results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Thalidomide (thalidomide)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Myeloma | NA | Status: TERMINATED | Results posted: 2019-04-29